<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03194828</url>
  </required_header>
  <id_info>
    <org_study_id>17-05074-XP</org_study_id>
    <nct_id>NCT03194828</nct_id>
  </id_info>
  <brief_title>Real-time Glaucoma Medication Adherence</brief_title>
  <official_title>Leveraging Real-Time Medication Use Monitoring to Improve Adherence in Adults With Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tennessee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kali Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Barney's Pharmacy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Creative Care Pharmacy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hutton Pharmacy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mustang Drug</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Tennessee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effectiveness of real-time data collected on patients taking
      topical medication to treat glaucoma. Patients will be randomized to two groups, the first of
      which will only use the study device to take their medication, while the second will use the
      study device and receive on-demand reminder messages, when necessary.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adherence to topical medications to treat glaucoma remains sub optimal; however, our
      understanding of this behavior remains limited due to biased measures of medication use. The
      Kali Drop device is a potential improvement in our ability to capture medication use in
      patients using dropper bottles by precisely capturing the amount dispensed in real-time.
      Moreover, such technology creates data that can be leveraged into driving behavior change
      using connected mobile technology in order to improve adherence and, ultimately, health
      outcomes. While evidence suggests that reminders may improve adherence to glaucoma
      medications, the power of doing so using real-time data has yet to be explored. This study
      will compare simple monitoring of patients to those who are being monitored and who receive
      reminder messages when the system determines one is necessary due to a missed dose.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 8, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence</measure>
    <time_frame>From study baseline through the 3 months of the intervention</time_frame>
    <description>Changes and differences in adherence to glaucoma medication between groups</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence follow-up</measure>
    <time_frame>From study endpoint through the subsequent 3 months</time_frame>
    <description>Changes and differences in adherence to glaucoma medication between groups after the intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medication self-efficacy using the 10-item Glaucoma Medication Adherence Self-Efficacy Scale</measure>
    <time_frame>Change from baseline over the 3-month intervention</time_frame>
    <description>Differences in self-reported medication-related self-efficacy between groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Monitoring only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will be given a real-time medication use monitor to use in dispensing their topical glaucoma medication for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monitoring and reminder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will be given a real-time medication use monitor to use in dispensing their topical glaucoma medication for 3 months and will receive an automated reminder (text or voice) when a missed dose is determined by the device's system</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Medication reminder</intervention_name>
    <description>Using the real-time data capture of the electronic device, an automated voice call or text message will be sent to active arm participants only when a missed dose is determined</description>
    <arm_group_label>Monitoring and reminder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Medication monitoring only</intervention_name>
    <description>Patients will use an electronic medication monitoring device to record their actual medication use</description>
    <arm_group_label>Monitoring only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age and older

          -  Glaucoma diagnosis

          -  Prescription for a prostaglandin indicated for glaucoma

          -  Nonadherent (MPR&lt;80%) in the last 3 months according to pharmacy records

          -  Owns and operates a mobile phone and willing to receive periodic reminder messages

        Exclusion Criteria:

          -  Existing chronic eye condition in addition to glaucoma

          -  Scheduled for eye surgery in the next 90 days

          -  Prescription for a medication that will not fit in the device

          -  Non-English speaking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justin Gatwood, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tennessee Health Science Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Justin Gatwood, PhD</last_name>
    <phone>6155323403</phone>
    <email>jgatwood@uthsc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Barney's Pharmacy</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley London, PharmD</last_name>
      <phone>706-798-5645</phone>
      <email>ashleyslondon@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ashley London, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emily Rourk, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kaitlyn Bastug, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barry Bryant, PharmD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barney's Pharmacy</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30907</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Newsome, PharmD</last_name>
      <phone>706-863-3456</phone>
      <email>newsomer67@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barney's Pharmacy</name>
      <address>
        <city>Grovetown</city>
        <state>Georgia</state>
        <zip>30813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Greg Regan, PharmD</last_name>
      <phone>706-869-8535</phone>
      <email>gregeregan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barney's Pharmacy</name>
      <address>
        <city>Louisville</city>
        <state>Georgia</state>
        <zip>30434</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Hayes, PharmD</last_name>
      <phone>478-625-8980</phone>
      <email>jshayes99@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hutton Pharmacy</name>
      <address>
        <city>Blackwell</city>
        <state>Oklahoma</state>
        <zip>74631</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clark Hutton, PharmD</last_name>
      <phone>580-363-2137</phone>
      <email>clark@huttonpharm.com</email>
    </contact>
    <investigator>
      <last_name>Clark Hutton, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Creative Care Pharmacy</name>
      <address>
        <city>Edmond</city>
        <state>Oklahoma</state>
        <zip>73013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phong Hoang, PharmD</last_name>
      <phone>405-562-1800</phone>
      <email>contact@creativecarerx.com</email>
    </contact>
    <contact_backup>
      <last_name>David George, PharmD, PhD</last_name>
      <phone>405-562-1800</phone>
      <email>davidg@creativecarerx.com</email>
    </contact_backup>
    <investigator>
      <last_name>Phong Hoang, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David George, PharmD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mustang Drug</name>
      <address>
        <city>Mustang</city>
        <state>Oklahoma</state>
        <zip>73064</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selma Alami, PharmD</last_name>
      <phone>405-256-0555</phone>
      <email>contact@mustangdrug.com</email>
    </contact>
    <investigator>
      <last_name>Selma Alami, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee College of Pharmacy</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2017</study_first_submitted>
  <study_first_submitted_qc>June 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2017</study_first_posted>
  <last_update_submitted>January 29, 2018</last_update_submitted>
  <last_update_submitted_qc>January 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adherence</keyword>
  <keyword>Mobile health</keyword>
  <keyword>Real-time data</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No IPD</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

